Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population

European Journal of Heart Failure

Volumn 12, Issue 8, 2010, Pages 861-865

  Hebert, Kathy ^a   Dias, Andre ^a   Delgado, Maria Carolina ^a,b   Franco, Emiliana ^a   Tamariz, Leonardo ^a   Steen, Dylan ^a   Trahan, Patrick ^c   Major, Brittny ^d   Arcement, Lee M ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Leonard J Chabert Medical Center   (United States)

^d Department of Biology   (United States)

Author keywords

Chronic kidney disease; Ethnicity; Gender; Heart failure; Mortality; Race

Indexed keywords

ADULT; ARTICLE; CAUCASIAN; CHRONIC KIDNEY DISEASE; ECHOCARDIOGRAPHY; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEGRO; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL RATE; SYSTOLIC HEART FAILURE; UNITED STATES;

AFRICAN AMERICANS; CONFIDENCE INTERVALS; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLORIDA; GLOMERULAR FILTRATION RATE; HEART FAILURE, SYSTOLIC; HISPANIC AMERICANS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LOUISIANA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTPATIENTS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955445090     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq077     Document Type: Article

References (19)

1. KDOQI. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 2007;49: S12-S154.
2. Campbell RC, Sui X, Filippatos G, Love TE, Wahle C, Sanders PW, Ahmed A. Association of chronic kidney disease with outcomes in chronic heart failure: a propensity-matched study. Nephrol Dial Transplant 2009;24:186-193.
3. Kazory A, Ross EA. Anemia: the point of convergence or divergence for kidney disease and heart failure? J Am Coll Cardiol 2009;53:639-647.
4. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics\2009 update: a report from the American Heart Association Statistics committee and stroke statistics subcommittee. Circulation 2009;119:480-486.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-S266.
6. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-188.
7. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third national health and nutrition examination survey. Am J Kidney Dis 2003;41:1-12.
8. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002;359:1686-1689
9. Centers for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors\United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2007;56:161-165.
10. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006;47:1987-1996.
11. Schaeffner ES, Kurth T, Bowman TS, Gelber RP, Gaziano JM. Blood pressure measures and risk of chronic kidney disease in men. Nephrol Dial Transplant 2008;23:1246-1251.
12. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996; 334:13-18.
13. Perneger TV, Whelton PK, Klag MJ. History of hypertension in patients treated for end-stage renal disease. J Hypertens 1997;15:451-456.
14. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43:S1-S290.
15. Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York: McGraw-Hill; 2001.
16. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI. Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Am Soc Nephrol 2009;4:1302-1311.
17. Young EW, Mauger EA, Jiang KH, Port FK, Wolfe RA. Socioeconomic status and end-stage renal disease in the United States. Kidney Int 1994;45:907-911.
18. Young JH, Klag MJ, Muntner P, Whyte JL, Pahor M, Coresh J. Blood pressure and decline in kidney function: findings from the systolic hypertension in the elderly program (SHEP). J Am Soc Nephrol 2002;13:2776-2782.
19. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease. socioeconomic status and access to health care as mediating factors. Arch Intern Med 1995; 155:1201-1208.